By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Gradalis Inc. 

2545 Golden Bear Drive
Suite 110
Carrollton  Texas  75006  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Gradalis Inc. Announces Presentation Of New Data 6/18/2014 9:09:41 AM
Gradalis Inc. Announces Dr. Scott Gottlieb Joins Board Of Directors 6/4/2014 9:03:30 AM
Gradalis Inc. Announces Appointment of Phillip B. Maples, Ph.D., as Executive Vice President and Chief Technical Officer 8/20/2013 6:14:41 AM
Ex-Prometheus Exec Tapped to Lead Gradalis Inc. 7/23/2013 6:37:53 AM
Gradalis Inc. Release: FANG™ Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer 5/16/2013 9:27:33 AM
Gradalis Inc. Closes $24 Million in Series B Financing 1/3/2013 7:25:50 AM
Baylor College of Medicine and Gradalis Inc. Enter Collaboration Agreement to Utilize Gradalis' Bifunctional shRNA Platform in Translational Medicine Research 7/11/2012 10:13:27 AM
Gradalis Inc. Release: Study Published in Molecular Therapy Shows that Immune Response to FANG(TM) Personalized Cancer Therapeutic Correlates with Prolonged Survival in Patients with Advanced Stage Cancer 3/1/2012 10:37:27 AM
Champions Biotechnology, Inc. (CSBR) Partners with Gradalis Inc. and Mary Crowley Cancer Research Center to Develop Personalized Vaccines for Cancer Patients 2/3/2009 9:37:01 AM
//-->